SAM
MACK

Silvercrest Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Silvercrest Asset Management’s Portfolio MACK Stock Details MACK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,180
Closed -$198K – 573
2015
Q4 		$198K Buy
+3,180
New +$198K ﹤0.01% 539
2015
Q3 		– Sell
-3,687
Closed -$359K – 508
2015
Q2 		$359K Buy
+3,687
New +$359K ﹤0.01% 425